查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1631196

幽门螺旋桿菌诊断市场分析报告：按类型、技术、最终用途、地区和细分市场预测，2025-2030 年

Helicobacter Pylori Diagnostics Market Analysis Report By Type (Instruments, Reagents, Services), By Technology (Immunoassays, POC, Molecular Diagnostics), By End Use, By Region And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

幽门螺旋桿菌诊断市场的成长和趋势

根据Grand View Research, Inc.的最新报告，全球幽门螺旋桿菌诊断市场规模预计到2030年将达到9.6619亿美元，2025年至2030年期间的复合年增长率为5.87%。个人化抗生素治疗需求的增加和成本效益的提高预计将推动幽门螺旋桿菌 (H. pylori) 感染诊断的成长。

抗生素的易得性和可负担性，以及较短的治疗时间，推动了抗生素的采用以及对治疗前后监测测试的需求。此外，幽门螺旋桿菌病菌感染上升、早期诊断的需求以及诊断技术的快速进步等因素将推动市场成长。然而，由于竞争激烈的环境而导致的维持价格的经济压力不断增加，可能会阻碍幽门螺旋桿菌诊断市场的成长。

幽门螺旋桿菌是一种需氧革兰氏阴性细菌，常见于胃。虽然它有利于维持平衡的胃生态系统，但它可能会导致胃黏膜感染。这种细菌可能是胃癌、十二指肠溃疡、胃炎和胃溃疡以及小肠感染疾病的病原体之一。因此，对能够早期检测病菌感染的幽门螺旋桿菌诊断药物的需求日益增加。如果确诊为幽门螺旋桿菌溃疡，患者将接受 10 至 14 天的抗生素治疗。幽门螺旋桿菌的治疗包括甲硝唑、阿莫西林、克拉霉素和四环霉素等抗生素的组合，以及质子帮浦抑制剂、雷尼替丁柠檬酸铋和次水杨酸铋的组合。

免疫测量技术部门在 2018 年占据了最大的市场占有率，预计在预测期内将实现最快的复合年增长率。根据最终用户，医院部门在 2018 年占据了最大的市场占有率，而诊断实验室预计在未来几年以最快的复合年增长率扩张。按地区划分，北美引领全球幽门螺旋桿菌诊断市场。另一方面，预计亚太地区在 2019 年至 2026 年期间的复合年增长率最快。

幽门螺旋桿菌诊断市场报告重点

  • 免疫测定技术将在 2024 年占据最大的市场占有率，预计在预测期内将以最快的复合年增长率成长。
  • 在终端用户中，医院部门预计将在 2024 年占据最大的市场占有率，而诊断实验室部门预计将在 2025 年至 2030 年间呈现最快的复合年增长率。
  • 由于医疗保健领域的重要性日益增加、感染疾病流行的增加以及人们意识的不断增强，预计预测期内拉丁美洲的复合年增长率将达到 6.4%。

目录

第一章调查方法与范围

第 2 章执行摘要

第 3 章市场变数、趋势与范围

  • 市场区隔和范围
  • 市场体系展望
    • 母市场展望
    • 相关/支持市场展望
  • 市场趋势与展望
  • 市场动态
  • 市场限制因素分析
  • 商业环境分析
    • 依因素（政治/法律、经济/技术）进行 SWOT 分析
    • 波特五力分析

第四章 类型业务分析

  • 幽门螺旋桿菌诊断市场：类型变异分析
  • 装置
    • 2018-2030 年装备市场
  • 试剂
    • 2018-2030 年试剂市场
  • 服务
    • 服务市场，2018-2030

第五章 技术业务分析

  • 幽门螺旋桿菌诊断市场：技术变迁分析
  • 免疫测定
    • 免疫测定市场，2018 - 2030
  • POC
    • POC 市场，2018-2030
  • 分子诊断
    • 分子诊断市场，2018 - 2030

第六章 最终用途业务分析

  • 幽门螺旋桿菌诊断市场：最终用途变异分析
  • 医院
    • 医院市场，2018-2030
  • 诊断实验室
    • 诊断实验室市场，2018-2030
  • 诊所
    • 诊所市场，2018-2030

第七章 区域经营分析

  • 2024 年及 2030 年幽门螺旋桿菌诊断市场占有率（按地区）
  • 北美洲
    • 2018 至 2030 年北美幽门螺旋桿菌诊断市场
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 2018 至 2030 年欧洲幽门螺旋桿菌诊断市场
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 2018 年至 2030 年亚太地区幽门螺旋桿菌诊断市场
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 拉丁美洲幽门螺旋桿菌诊断市场，2018-2030 年
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 中东和非洲幽门螺旋桿菌诊断市场，2018-2030 年
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 公司分类
  • 战略地图
  • 2024 年公司市场占有率分析
  • 公司简介/上市公司
    • Biohit Oyj
    • Thermo Fisher Scientific, Inc.
    • Quest Diagnostics Incorporated
    • Meridian Bioscience
    • Bio-Rad Laboratories
    • Alpha Laboratories Ltd
    • Coris BioConcept
    • F. Hoffmann-La Roche AG
    • Certest BIoTec
    • Epitope Diagnostics, Inc.
Product Code: GVR-3-68038-699-8

Helicobacter Pylori Diagnostics Market Growth & Trends:

The global helicobacter pylori diagnostics market size is anticipated to reach USD 966.19 million by 2030, expanding at a CAGR of 5.87% from 2025 to 2030, according to a new report by Grand View Research. Increasing demand for personalized antibiotic therapy coupled with improved cost-effectiveness Helicobacter pylori (H. pylori) infection diagnosis is projected to drive the growth.

Easy accessibility and affordability of antibiotics along with short treatment durations will boost the adoption of antibiotics as well as the demand for pre and post monitoring tests. Furthermore, factors such as rising incidence of H. pylori infections, need for early diagnosis, and rapid technological advancements in diagnostic techniques will propel the market growth. However, rising pressure of maintaining economic pricing due to the extremely competitive environment may hinder the growth of the Helicobacter pylori diagnostics market.

H. pylori is an aerobic gram-negative bacteria generally found in the stomach. Although advantageous for balancing the stomach ecology, it can cause infection to the inner stomach lining. The bacteria can act as one of the causative agents for stomach cancer, duodenal ulcers, gastritis and gastric ulcers, and infection to the small intestine, among other conditions. This has led to an increase in the demand for Helicobacter pylori diagnostics that enable early detection of H. pylori infection. Patients are subject to an antibiotic therapy for 10 to 14 days, in case of positive diagnosis of ulcers caused by this bacteria. Treatment for H. pylori could include a combination of antibiotics such as metronidazole, amoxicillin, clarithromycin, tetracycline, or with a proton pump inhibitor, ranitidine bismuth citrate, and bismuth subsalicylate.

The immunoassay technology segment held the largest market share in 2018 and is expected to register the fastest CAGR over the forecast period. In terms of end user, the hospital segment held the largest market share in 2018, while diagnostic laboratories is anticipated to expand at the fastest CAGR in the forthcoming years. In terms of region, North America led the global market for Helicobacter pylori diagnostics. Asia Pacific, on the other hand, is expected to witness the fastest CAGR from 2019 to 2026.

Helicobacter Pylori Diagnostics Market Report Highlights:

  • Immunoassays technology held the largest market share in 2024 and is expected to witness the fastest CAGR over the forecast period
  • Among end user, hospital segment held the largest market share in 2024, while the diagnostics laboratories segment is expected to demonstrate the fastest CAGR from 2025 to 2030
  • Latin America is anticipated to grow at the fastest CAGR of 6.4% in the forecast period owing to the rising importance to the healthcare sector, increasing infectious diseases prevalence, and awareness.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Information Procurement
  • 1.2. Information or Data Analysis
  • 1.3. Market Scope & Segment Definition
  • 1.4. Market Model
    • 1.4.1. Market Study, By Company Market Share
    • 1.4.2. Regional Analysis

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Trends and Outlook
  • 3.4. Market Dynamics
  • 3.5. Market Restraint Analysis
  • 3.6. Business Environment Analysis
    • 3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
    • 3.6.2. Porter's Five Forces Analysis

Chapter 4. Type Business Analysis

  • 4.1. Helicobacter Pylori Diagnostics Market: Type Movement Analysis
  • 4.2. Instruments
    • 4.2.1. Instruments Market, 2018 - 2030 (USD Million)
  • 4.3. Reagents
    • 4.3.1. Reagents Market, 2018 - 2030 (USD Million)
  • 4.4. Services
    • 4.4.1. Services Market, 2018 - 2030 (USD Million)

Chapter 5. Technology Business Analysis

  • 5.1. Helicobacter Pylori Diagnostics Market: Technology Movement Analysis
  • 5.2. Immunoassays
    • 5.2.1. Immunoassays Market, 2018 - 2030 (USD Million)
  • 5.3. POC
    • 5.3.1. POC Market, 2018 - 2030 (USD Million)
  • 5.4. Molecular Diagnostics
    • 5.4.1. Molecular Diagnostics Market, 2018 - 2030 (USD Million)

Chapter 6. End use Business Analysis

  • 6.1. Helicobacter Pylori Diagnostics Market: End use Movement Analysis
  • 6.2. Hospitals
    • 6.2.1. Hospitals Market, 2018 - 2030 (USD Million)
  • 6.3. Diagnostics Laboratories
    • 6.3.1. Diagnostics Laboratories Market, 2018 - 2030 (USD Million)
  • 6.4. Clinics
    • 6.4.1. Clinics Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Helicobacter Pylori Diagnostics Market Share By Region, 2024 & 2030
  • 7.2. North America
    • 7.2.1. North America Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. Key Country Dynamics
      • 7.2.2.2. Target Disease Prevalence
      • 7.2.2.3. Competitive Scenario
      • 7.2.2.4. Regulatory Framework
      • 7.2.2.5. Reimbursement Scenario
      • 7.2.2.6. U.S. Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Target Disease Prevalence
      • 7.2.3.3. Competitive Scenario
      • 7.2.3.4. Regulatory Framework
      • 7.2.3.5. Reimbursement Scenario
      • 7.2.3.6. Canada Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Key Country Dynamics
      • 7.2.4.2. Target Disease Prevalence
      • 7.2.4.3. Competitive Scenario
      • 7.2.4.4. Regulatory Framework
      • 7.2.4.5. Reimbursement Scenario
      • 7.2.4.6. Mexico Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.3.2. Germany
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Target Disease Prevalence
      • 7.3.2.3. Competitive Scenario
      • 7.3.2.4. Regulatory Framework
      • 7.3.2.5. Reimbursement Scenario
      • 7.3.2.6. Germany Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.3.3. UK
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Target Disease Prevalence
      • 7.3.3.3. Competitive Scenario
      • 7.3.3.4. Regulatory Framework
      • 7.3.3.5. Reimbursement Scenario
      • 7.3.3.6. UK Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Target Disease Prevalence
      • 7.3.4.3. Competitive Scenario
      • 7.3.4.4. Regulatory Framework
      • 7.3.4.5. Reimbursement Scenario
      • 7.3.4.6. France Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Target Disease Prevalence
      • 7.3.5.3. Competitive Scenario
      • 7.3.5.4. Regulatory Framework
      • 7.3.5.5. Reimbursement Scenario
      • 7.3.5.6. Italy Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Target Disease Prevalence
      • 7.3.6.3. Competitive Scenario
      • 7.3.6.4. Regulatory Framework
      • 7.3.6.5. Reimbursement Scenario
      • 7.3.6.6. Spain Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Target Disease Prevalence
      • 7.3.7.3. Competitive Scenario
      • 7.3.7.4. Regulatory Framework
      • 7.3.7.5. Reimbursement Scenario
      • 7.3.7.6. Denmark Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Target Disease Prevalence
      • 7.3.8.3. Competitive Scenario
      • 7.3.8.4. Regulatory Framework
      • 7.3.8.5. Reimbursement Scenario
      • 7.3.8.6. Sweden Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Target Disease Prevalence
      • 7.3.9.3. Competitive Scenario
      • 7.3.9.4. Regulatory Framework
      • 7.3.9.5. Reimbursement Scenario
      • 7.3.9.6. Norway Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Target Disease Prevalence
      • 7.4.2.3. Competitive Scenario
      • 7.4.2.4. Regulatory Framework
      • 7.4.2.5. Reimbursement Scenario
      • 7.4.2.6. Japan Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Target Disease Prevalence
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. Regulatory Framework
      • 7.4.3.5. Reimbursement Scenario
      • 7.4.3.6. China Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Target Disease Prevalence
      • 7.4.4.3. Competitive Scenario
      • 7.4.4.4. Regulatory Framework
      • 7.4.4.5. Reimbursement Scenario
      • 7.4.4.6. India Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.4.5. South Korea
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Target Disease Prevalence
      • 7.4.5.3. Competitive Scenario
      • 7.4.5.4. Regulatory Framework
      • 7.4.5.5. Reimbursement Scenario
      • 7.4.5.6. South Korea Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Target Disease Prevalence
      • 7.4.6.3. Competitive Scenario
      • 7.4.6.4. Regulatory Framework
      • 7.4.6.5. Reimbursement Scenario
      • 7.4.6.6. Australia Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Target Disease Prevalence
      • 7.4.7.3. Competitive Scenario
      • 7.4.7.4. Regulatory Framework
      • 7.4.7.5. Reimbursement Scenario
      • 7.4.7.6. Thailand Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Target Disease Prevalence
      • 7.5.2.3. Competitive Scenario
      • 7.5.2.4. Regulatory Framework
      • 7.5.2.5. Reimbursement Scenario
      • 7.5.2.6. Brazil Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Target Disease Prevalence
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. Regulatory Framework
      • 7.5.3.5. Reimbursement Scenario
      • 7.5.3.6. Argentina Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. MEA Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Target Disease Prevalence
      • 7.6.2.3. Competitive Scenario
      • 7.6.2.4. Regulatory Framework
      • 7.6.2.5. Reimbursement Scenario
      • 7.6.2.6. South Africa Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Target Disease Prevalence
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. Regulatory Framework
      • 7.6.3.5. Reimbursement Scenario
      • 7.6.3.6. Saudi Arabia Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Target Disease Prevalence
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. Regulatory Framework
      • 7.6.4.5. Reimbursement Scenario
      • 7.6.4.6. UAE Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Target Disease Prevalence
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. Regulatory Framework
      • 7.6.5.5. Reimbursement Scenario
      • 7.6.5.6. Kuwait Helicobacter pylori diagnostics Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Share Analysis, 2024
  • 8.4. Company Profiles/Listing
    • 8.4.1. Biohit Oyj
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.1.3. Collection Site Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Thermo Fisher Scientific, Inc.
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.2.3. Collection Site Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Quest Diagnostics Incorporated
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.3.3. Collection Site Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Meridian Bioscience
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.4.3. Collection Site Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Bio-Rad Laboratories
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.5.3. Collection Site Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Alpha Laboratories Ltd
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.6.3. Collection Site Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Coris BioConcept
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.7.3. Collection Site Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. F. Hoffmann-La Roche AG
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.8.3. Collection Site Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Certest Biotec
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.9.3. Collection Site Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. Epitope Diagnostics, Inc.
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.10.3. Collection Site Benchmarking
      • 8.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 4 Global Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 5 Global Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 6 Global Helicobacter Pylori Diagnostics Market, by Region, 2018 - 2030 (USD Million)
  • Table 7 North America Helicobacter Pylori Diagnostics Market, by Country, 2018 - 2030 (USD Million)
  • Table 8 North America Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 9 North America Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 10 North America Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 11 U.S. Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 12 U.S. Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 13 U.S. Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 14 Mexico Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 15 Mexico Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 16 Mexico Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 17 Canada Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 18 Canada Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 19 Canada Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 20 Europe Helicobacter Pylori Diagnostics Market, by Country, 2018 - 2030 (USD Million)
  • Table 21 Europe Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 22 Europe Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 23 Europe Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 24 Germany Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 25 Germany Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 26 Germany Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 27 UK Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 28 UK Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 29 UK Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 30 France Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 31 France Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 32 France Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 33 Italy Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 34 Italy Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 35 Italy Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 36 Spain Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 37 Spain Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 38 Spain Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 39 Denmark Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 40 Denmark Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 41 Denmark Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 42 Sweden Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 43 Sweden Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 44 Sweden Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 45 Norway Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 46 Norway Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 47 Norway Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Helicobacter Pylori Diagnostics Market, by Country, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 52 China Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 53 China Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 54 China Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 55 Japan Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 56 Japan Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 57 Japan Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 58 India Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 59 India Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 60 India Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 61 South Korea Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 62 South Korea Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 63 South Korea Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 64 Australia Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 65 Australia Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 66 Australia Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 67 Thailand Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 68 Thailand Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 69 Thailand Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 70 Latin America Helicobacter Pylori Diagnostics Market, by Country, 2018 - 2030 (USD Million)
  • Table 71 Latin America Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 72 Latin America Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 73 Latin America Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 74 Brazil Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 75 Brazil Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 76 Brazil Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 77 Argentina Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 78 Argentina Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 79 Argentina Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Helicobacter Pylori Diagnostics Market, by Country, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 84 South Africa Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 85 South Africa Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 86 South Africa Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 90 UAE Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 91 UAE Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 92 UAE Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Helicobacter Pylori Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Helicobacter Pylori Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 95 Kuwait Helicobacter Pylori Diagnostics Market, by End use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Helicobacter Pylori Diagnostics Market Segmentation
  • Fig. 8 Market Snapshot, 2024
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Global Helicobacter Pylori Diagnostics Market: Type Movement Analysis
  • Fig. 16 Global Helicobacter Pylori Diagnostics Market: for Instruments, 2018 - 2030 (USD Million)
  • Fig. 17 Global Helicobacter Pylori Diagnostics Market: for Reagents, 2018 - 2030 (USD Million)
  • Fig. 18 Global Helicobacter Pylori Diagnostics Market: for Services, 2018 - 2030 (USD Million)
  • Fig. 19 Global Helicobacter Pylori Diagnostics Market: Technology Movement Analysis
  • Fig. 20 Global Helicobacter Pylori Diagnostics Market: for Immunoassays, 2018 - 2030 (USD Million)
  • Fig. 21 Global Helicobacter Pylori Diagnostics Market: for POC, 2018 - 2030 (USD Million)
  • Fig. 22 Global Helicobacter Pylori Diagnostics Market: for Molecular Diagnostics, 2018 - 2030 (USD Million)
  • Fig. 23 Global Helicobacter Pylori Diagnostics Market: End use Movement Analysis
  • Fig. 24 Global Helicobacter Pylori Diagnostics Market: for Hospitals, 2018 - 2030 (USD Million)
  • Fig. 25 Global Helicobacter Pylori Diagnostics Market: for Diagnostics Laboratories, 2018 - 2030 (USD Million)
  • Fig. 26 Global Helicobacter Pylori Diagnostics Market: for Clinics, 2018 - 2030 (USD Million)
  • Fig. 27 Regional Marketplace: Key Takeaways
  • Fig. 28 Regional Outlook, 2024 & 2030
  • Fig. 29 Global Helicobacter Pylori Diagnostics Market: Region Movement Analysis
  • Fig. 30 North America Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 31 U.S. Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 32 Canada Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 33 Mexico Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 34 Europe Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 35 Germany Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 36 UK Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 37 France Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 38 Italy Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 39 Spain Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 40 Denmark Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 41 Sweden Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 42 Norway Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 43 Asia Pacific Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 44 Japan Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 45 China Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 46 India Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 47 Australia Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 48 South Korea Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 49 Thailand Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 50 Latin America Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 51 Brazil Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 52 Argentina Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 53 Middle East and Africa Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 54 South Africa Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 55 Saudi Arabia Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 56 UAE Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)
  • Fig. 57 Kuwait Helicobacter Pylori Diagnostics Market: 2018 - 2030 (USD Million)